Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Kataoka M, Antoniou A, Warren R, Leyland J, Brown J, Audley T, Easton D. Genetic models for the familial aggregation of mammographic breast density. Cancer Epidemiol Biomarkers Prev 2009;18:1277-84. [PMID: 19336563 DOI: 10.1158/1055-9965.epi-08-0568] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

For:	Kataoka M, Antoniou A, Warren R, Leyland J, Brown J, Audley T, Easton D. Genetic models for the familial aggregation of mammographic breast density. Cancer Epidemiol Biomarkers Prev 2009;18:1277-84. [PMID: 19336563 DOI: 10.1158/1055-9965.epi-08-0568] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Number

Cited by Other Article(s)

Kataoka M. Mammographic Density for Personalized Breast Cancer Risk. Radiology 2023;306:e222129. [PMID: 36125381 DOI: 10.1148/radiol.222129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]

Dumont M, Weber-Lassalle N, Joly-Beauparlant C, Ernst C, Droit A, Feng BJ, Dubois S, Collin-Deschesnes AC, Soucy P, Vallée M, Fournier F, Lemaçon A, Adank MA, Allen J, Altmüller J, Arnold N, Ausems MGEM, Berutti R, Bolla MK, Bull S, Carvalho S, Cornelissen S, Dufault MR, Dunning AM, Engel C, Gehrig A, Geurts-Giele WRR, Gieger C, Green J, Hackmann K, Helmy M, Hentschel J, Hogervorst FBL, Hollestelle A, Hooning MJ, Horváth J, Ikram MA, Kaulfuß S, Keeman R, Kuang D, Luccarini C, Maier W, Martens JWM, Niederacher D, Nürnberg P, Ott CE, Peters A, Pharoah PDP, Ramirez A, Ramser J, Riedel-Heller S, Schmidt G, Shah M, Scherer M, Stäbler A, Strom TM, Sutter C, Thiele H, van Asperen CJ, van der Kolk L, van der Luijt RB, Volk AE, Wagner M, Waisfisz Q, Wang Q, Wang-Gohrke S, Weber BHF, Devilee P, Tavtigian S, Bader GD, Meindl A, Goldgar DE, Andrulis IL, Schmutzler RK, Easton DF, Schmidt MK, Hahnen E, Simard J. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry. Cancers (Basel) 2022;14:cancers14143363. [PMID: 35884425 PMCID: PMC9317824 DOI: 10.3390/cancers14143363] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 06/29/2022] [Accepted: 07/01/2022] [Indexed: 01/27/2023] Open

Affiliation(s)

Martine Dumont Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Nana Weber-Lassalle Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; (N.W.-L.); (C.E.); (R.K.S.); (E.H.)
Charles Joly-Beauparlant Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Corinna Ernst Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; (N.W.-L.); (C.E.); (R.K.S.); (E.H.)
Arnaud Droit Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Bing-Jian Feng Department of Dermatology, University of Utah, Salt Lake City, UT 84103, USA; (B.-J.F.); (D.E.G.) Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA;
Stéphane Dubois Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Annie-Claude Collin-Deschesnes Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Penny Soucy Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Maxime Vallée Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Frédéric Fournier Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Audrey Lemaçon Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.)
Muriel A. Adank Family Cancer Clinic, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (M.A.A.); (F.B.L.H.); (L.v.d.K.)
Jamie Allen Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.)
Janine Altmüller Cologne Center for Genomics (CCG), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; (J.A.); (H.T.)
Norbert Arnold Institute of Clinical Molecular Biology, Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, 24105 Kiel, Germany;
Margreet G. E. M. Ausems Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, 3584 Utrecht, The Netherlands;
Riccardo Berutti Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany; (R.B.); (T.M.S.)
Manjeet K. Bolla Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.)
Shelley Bull Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada; (S.B.); (J.G.); (G.D.B.); (I.L.A.) Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada
Sara Carvalho Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.)
Sten Cornelissen Division of Molecular Pathology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (S.C.); (R.K.); (M.K.S.)
Michael R. Dufault Precision Medicine and Computational Biology, Sanofi Genzyme, Cambridge, MA 02142, USA;
Alison M. Dunning Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK; (A.M.D.); (C.L.); (M.S.)
Christoph Engel Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107 Leipzig, Germany;
Andrea Gehrig Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, 97074 Würzburg, Germany;
Willemina R. R. Geurts-Giele Department of Clinical Genetics, Erasmus University Medical Center, 3015 Rotterdam, The Netherlands;
Christian Gieger Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; (C.G.); (A.P.) Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, 85764 Neuherberg, Germany
Jessica Green Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada; (S.B.); (J.G.); (G.D.B.); (I.L.A.) Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada;
Karl Hackmann Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany;
Mohamed Helmy The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138632, Singapore Department of Computer Science, Lakehead University, Thunder Bay, ON P7B 5E1, Canada
Julia Hentschel Institute of Human Genetics, University Leipzig, 04103 Leipzig, Germany;
Frans B. L. Hogervorst Family Cancer Clinic, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (M.A.A.); (F.B.L.H.); (L.v.d.K.)
Antoinette Hollestelle Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands; (A.H.); (M.J.H.); (J.W.M.M.)
Maartje J. Hooning Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands; (A.H.); (M.J.H.); (J.W.M.M.)
Judit Horváth Institute of Human Genetics, University of Münster, 48149 Münster, Germany;
M. Arfan Ikram Department of Epidemiology, Erasmus MC University Medical Center, 3015 Rotterdam, The Netherlands;
Silke Kaulfuß Institute of Human Genetics, University Medical Center Göttingen, 37075 Göttingen, Germany;
Renske Keeman Division of Molecular Pathology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (S.C.); (R.K.); (M.K.S.)
Da Kuang Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada;
Craig Luccarini Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK; (A.M.D.); (C.L.); (M.S.)
Wolfgang Maier German Center for Neurodegenerative Diseases (DZNE), Department of Neurodegenerative Diseases and Geriatric Psychiatry, Medical Faculty, University Hospital Bonn, 53127 Bonn, Germany;
John W. M. Martens Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands; (A.H.); (M.J.H.); (J.W.M.M.)
Dieter Niederacher Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany;
Peter Nürnberg Center for Molecular Medicine Cologne (CMMC), Cologne Center for Genomics (CCG), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany;
Claus-Eric Ott Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 13353 Berlin, Germany;
Annette Peters Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; (C.G.); (A.P.) Department of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, 80539 Munich, Germany
Paul D. P. Pharoah Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.) Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK; (A.M.D.); (C.L.); (M.S.)
Alfredo Ramirez Division for Neurogenetics and Molecular Psychiatry, Medical Faculty, University of Cologne, 50937 Cologne, Germany;
Juliane Ramser Division of Gynaecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität München, 81675 Munich, Germany; (J.R.); (A.M.)
Steffi Riedel-Heller Institute of Social Medicine, Occupational Health and Public Health, Faculty of Medicine, University of Leipzig, 04103 Leipzig, Germany;
Gunnar Schmidt Institute of Human Genetics, Hannover Medical School, 30625 Hannover, Germany;
Mitul Shah Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK; (A.M.D.); (C.L.); (M.S.)
Martin Scherer Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany;
Antje Stäbler Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany;
Tim M. Strom Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany; (R.B.); (T.M.S.)
Christian Sutter Institute of Human Genetics, University Hospital Heidelberg, 69120 Heidelberg, Germany;
Holger Thiele Cologne Center for Genomics (CCG), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; (J.A.); (H.T.)
Christi J. van Asperen Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, The Netherlands; (C.J.v.A.); (R.B.v.d.L.)
Lizet van der Kolk Family Cancer Clinic, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (M.A.A.); (F.B.L.H.); (L.v.d.K.)
Rob B. van der Luijt Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, The Netherlands; (C.J.v.A.); (R.B.v.d.L.) Department of Medical Genetics, University Medical Center, 3584 Utrecht, The Netherlands
Alexander E. Volk Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany;
Michael Wagner Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, 53127 Bonn, Germany;
Quinten Waisfisz Department of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 Amsterdam, The Netherlands;
Qin Wang Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.)
Shan Wang-Gohrke Department of Gynaecology and Obstetrics, University of Ulm, 89081 Ulm, Germany;
Bernhard H. F. Weber Institute of Human Genetics, Regensburg University, 93053 Regensburg, Germany; Institute of Clinical Human Genetics, University Hospital Regensburg, 93053 Regensburg, Germany
Genome of the Netherlands Project
GHS Study Group
Peter Devilee Department of Pathology, Department of Human Genetics, Leiden University Medical Center, 2333 Leiden, The Netherlands;
Sean Tavtigian Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
Gary D. Bader Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada; (S.B.); (J.G.); (G.D.B.); (I.L.A.) Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5S 3E1, Canada Princess Margaret Research Institute, University Health Network, Toronto, ON M5G 0A3, Canada
Alfons Meindl Division of Gynaecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität München, 81675 Munich, Germany; (J.R.); (A.M.)
David E. Goldgar Department of Dermatology, University of Utah, Salt Lake City, UT 84103, USA; (B.-J.F.); (D.E.G.) Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA;
Irene L. Andrulis Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada; (S.B.); (J.G.); (G.D.B.); (I.L.A.) Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada;
Rita K. Schmutzler Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; (N.W.-L.); (C.E.); (R.K.S.); (E.H.)
Douglas F. Easton Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; (J.A.); (M.K.B.); (S.C.); (P.D.P.P.); (Q.W.); (D.F.E.) Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK; (A.M.D.); (C.L.); (M.S.)
Marjanka K. Schmidt Division of Molecular Pathology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands; (S.C.); (R.K.); (M.K.S.) Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, The Netherlands
Eric Hahnen Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; (N.W.-L.); (C.E.); (R.K.S.); (E.H.)
Jacques Simard Genomics Center, CHU de Québec-Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, QC GIV 4G2, Canada; (M.D.); (C.J.-B.); (A.D.); (S.D.); (A.-C.C.-D.); (P.S.); (M.V.); (F.F.); (A.L.) Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec, QC G1V 0A6, Canada Correspondence: ; Tel.: +418-654-2264

Collapse

Evans DG, van Veen EM, Howell A, Astley S. Heritability of mammographic breast density. Quant Imaging Med Surg 2020;10:2387-2391. [PMID: 33269237 DOI: 10.21037/qims-2020-20] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]

Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women. PLoS One 2019;14:e0216114. [PMID: 31067262 PMCID: PMC6505928 DOI: 10.1371/journal.pone.0216114] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2018] [Accepted: 04/15/2019] [Indexed: 11/19/2022] Open

Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Ahmed S, Baynes C, Conroy DM, Brown J, Luben R, Ostrander EA, Pharoah PD, Dunning AM, Easton DF. Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. J Med Genet 2017;54:732-741. [PMID: 28779002 PMCID: PMC5740532 DOI: 10.1136/jmedgenet-2017-104588] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2017] [Revised: 05/09/2017] [Accepted: 05/22/2017] [Indexed: 12/30/2022]

Affiliation(s)

Brennan Decker Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
Jamie Allen Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Craig Luccarini Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Karen A Pooley Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Mitul Shah Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Manjeet K Bolla Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Qin Wang Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Shahana Ahmed Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Caroline Baynes Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Don M Conroy Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Judith Brown Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Robert Luben Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Elaine A Ostrander Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
Paul Dp Pharoah Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Alison M Dunning Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Douglas F Easton Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK

Collapse

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomäki K, Anton-Culver H, Arndt V, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, García-Closas M, Giles GG, Glendon G, González-Neira A, Guénel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D, Kosma VM, Kristensen V, Lambrechts D, Li N, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkäs K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RAEM, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dörk T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PDP, Campbell IG, Dunning AM, Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trench G. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet 2016;53:298-309. [PMID: 26921362 PMCID: PMC4938802 DOI: 10.1136/jmedgenet-2015-103529] [Citation(s) in RCA: 81] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2015] [Accepted: 12/16/2015] [Indexed: 12/13/2022]

Affiliation(s)

Douglas F Easton Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Fabienne Lesueur Genetic Epidemiology of Cancer team, Inserm, U900, Institut Curie, Mines ParisTech, Paris, France
Brennan Decker Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Cancer Genetics and Comparative Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
Kyriaki Michailidou Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
Jun Li Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Jamie Allen Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Craig Luccarini Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Karen A Pooley Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Mitul Shah Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Manjeet K Bolla Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Qin Wang Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Joe Dennis Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Jamil Ahmad Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Ella R Thompson Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Francesca Damiola Genetic of Breast Cancer Team, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France
Maroulio Pertesi Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Catherine Voegele Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Noura Mebirouk Genetic Epidemiology of Cancer team, Inserm, U900, Institut Curie, Mines ParisTech, Paris, France
Nivonirina Robinot Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Geoffroy Durand Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Nathalie Forey Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
Robert N Luben Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Shahana Ahmed Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Kristiina Aittomäki Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Hoda Anton-Culver Department of Epidemiology, University of California Irvine, Irvine, California, USA
Volker Arndt Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
Caroline Baynes Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Matthias W Beckman Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
Javier Benitez Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain
David Van Den Berg Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
William J Blot International Epidemiology Institute, Rockville, Maryland, USA Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Natalia V Bogdanova Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
Stig E Bojesen Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Hermann Brenner Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
Jenny Chang-Claude Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Kee Seng Chia Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
Ji-Yeob Choi Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea
Don M Conroy Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Angela Cox Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK
Simon S Cross Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK
Kamila Czene Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Hatef Darabi Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Peter Devilee Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
Mikael Eriksson Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Peter A Fasching Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California, Los Angeles, California, USA
Jonine Figueroa Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK
Henrik Flyger Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
Florentia Fostira Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece
Montserrat García-Closas Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
Graham G Giles Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
Gord Glendon Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada
Anna González-Neira Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain
Pascal Guénel University Paris-Sud, UMRS 1018, Villejuif, France Inserm, CESP Center for research in Epidemiology and Population Health, U1018, Cancer & Environment Group, Villejuif, France
Christopher A Haiman Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Per Hall Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Steven N Hart Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
Mikael Hartman Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore Department of Surgery, National University Health System, Singapore, Singapore
Maartje J Hooning Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands
Chia-Ni Hsiung Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
Hidemi Ito Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan
Anna Jakubowska Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Paul A James Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Esther M John Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA
Nichola Johnson Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Michael Jones Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
Maria Kabisch Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Daehee Kang Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea Department of Preventive Medicine, Seoul National University College of Medicine, Seoul National University, Seoul, Korea
Veli-Matti Kosma Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
Vessela Kristensen Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway Faculty of Medicine, K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway Department of Clinical Molecular Biology (EpiGen), University of Oslo (UiO), Oslo, Norway
Diether Lambrechts Vesalius Research Center, VIB, Leuven, Belgium Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium
Na Li Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Annika Lindblom Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Jirong Long Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Artitaya Lophatananon Division of Health Sciences, Warwick Medical school, Warwick University, Coventry, UK
Jan Lubinski Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Arto Mannermaa Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
Siranoush Manoukian Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy
Sara Margolin Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Keitaro Matsuo Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
Alfons Meindl Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany
Gillian Mitchell Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Kenneth Muir Division of Health Sciences, Warwick Medical school, Warwick University, Coventry, UK Institute of Population Health, University of Manchester, Manchester, UK
Ines Nevelsteen University Hospital Gashuisberg, Leuven, Belgium
Ans van den Ouweland Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
Paolo Peterlongo IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy
Sze Yee Phuah Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia
Katri Pylkäs Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland Laboratory of Cancer Genetics and Tumor Biology, Cancer Research and Translational Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland
Simone M Rowley Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia
Suleeporn Sangrajrang National Cancer Institute, Bangkok, Thailand
Rita K Schmutzler Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany Medical Faculty, Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Germany Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany
Chen-Yang Shen School of Public Health, China Medical University, Taichung, Taiwan Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
Xiao-Ou Shu Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Melissa C Southey Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia
Harald Surowy Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany
Anthony Swerdlow Division of Breast Cancer Research, The Institute of Cancer Research, London, UK Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
Soo H Teo Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia
Rob A E M Tollenaar Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
Ian Tomlinson Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
Diana Torres Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia
Thérèse Truong University Paris-Sud, UMRS 1018, Villejuif, France Inserm, CESP Center for research in Epidemiology and Population Health, U1018, Cancer & Environment Group, Villejuif, France
Celine Vachon Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
Senno Verhoef Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
Michelle Wong-Brown Division of Genetics, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia
Wei Zheng Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Ying Zheng Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China
Heli Nevanlinna Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Rodney J Scott Division of Genetics, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia
Irene L Andrulis Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada Department of Molecular Genetics, University of Toronto, Ontario, Canada
Anna H Wu Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
John L Hopper Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Victoria, Australia
Fergus J Couch Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
Robert Winqvist Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland Laboratory of Cancer Genetics and Tumor Biology, Cancer Research and Translational Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland
Barbara Burwinkel Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany
Elinor J Sawyer Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, UK
Marjanka K Schmidt Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
Anja Rudolph Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Thilo Dörk Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
Hiltrud Brauch German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany University of Tübingen, Tübingen, Germany
Ute Hamann Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Susan L Neuhausen Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA
Roger L Milne Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
Olivia Fletcher Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Paul D P Pharoah Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Ian G Campbell Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia
Alison M Dunning Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
Florence Le Calvez-Kelm Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
David E Goldgar Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah, USA
Sean V Tavtigian Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA
Georgia Chenevix-Trench Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia

Collapse

Ramón Y Cajal T, Chirivella I, Miranda J, Teule A, Izquierdo Á, Balmaña J, Sánchez-Heras AB, Llort G, Fisas D, Lope V, Hernández-Agudo E, Juan-Fita MJ, Tena I, Robles L, Guillén-Ponce C, Pérez-Segura P, Luque-Molina MS, Hernando-Polo S, Salinas M, Brunet J, Salas-Trejo MD, Barnadas A, Pollán M. Mammographic density and breast cancer in women from high risk families. Breast Cancer Res 2015;17:93. [PMID: 26163143 PMCID: PMC4499171 DOI: 10.1186/s13058-015-0604-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Accepted: 06/24/2015] [Indexed: 11/15/2022] Open

Abstract

Introduction

Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype.

Methods

The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units. Participants’ density was scored retrospectively from available mammograms by a single blinded radiologist using a 5-category scale (<10 %, 10-25 %, 25-50 %, 50-75 %, >75 %). In BC cases, we selected mammograms taken prior to diagnosis or from the contralateral breast, whereas, in non-cases, the last screening mammogram was evaluated. MD distribution in carriers and non-carriers was compared using ordinal logistic models, and the association between MD and BC in BRCA1/2 mutation carriers was studied using logistic regression. Huber-White robust estimators of variance were used to take into account correlations between family members. A similar multinomial model was used to explore this association by BC subtype.

Results

We identified and scored mammograms from 341 BRCA1, 350 BRCA2 mutation carriers and 229 non-carriers. Compared to non-carriers, MD was significantly lower among BRCA2 mutation carriers (odds ratio (OR) =0.71; P-value=0.04), but not among BRCA1 carriers (OR=0.84; P-value=0.33). MD was associated with subsequent development BC (OR per category of MD=1.45; 95 % confidence interval=1.18-1.78, P-value<0.001), with no significant differences between BRCA1 and BRCA2 mutation carriers (P-value=0.48). Finally, no statistically significant differences were observed in the association of MD with specific BC subtypes.

Conclusions

Our study, the largest to date on this issue, confirms that MD is an independent risk factor for all BC subtypes in either BRCA1 and BRCA2 mutation carriers, and should be considered a phenotype risk marker in this context.

Collapse

Affiliation(s)

Teresa Ramón Y Cajal Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Isabel Chirivella Medical Oncology Department, Hospital Clinico Universitario de Valencia, Valencia, Spain.
Josefa Miranda Foundation General Directorate Public Health and Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, FISABIO - Public Health, Valencia, Spain.
Alexandre Teule Hereditary Cancer Program, Catalan Institue of Oncology-IDIBELL, Barcelona, Spain.
Ángel Izquierdo Hereditary Cancer Program, Catalan Institute of Oncology-IDIBGI, Girona, Spain.
Judith Balmaña Medical Oncology Deartment, Hospital Vall Hebron/Vall Hebron Institute of Oncology, Barcelona, Spain.
Ana Beatriz Sánchez-Heras Medical Oncology Department, Hospital Universitario de Elche, Elche, Spain.
Gemma Llort Genetic Counseling Unit, Corporació Sanitaria Parc tauli, Consorci Sanitari de Terrassa, Terrasa, Spain.
David Fisas Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Virginia Lope National Center for Epidemiology, Carlos III Institute of Health, Monforte de Lemos 5, 28029, Madrid, Spain. .,Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain. .,Consortium Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain.
Elena Hernández-Agudo Breast Cancer Unit, Clinical Research Programme, Spanish National Cancer Center (CNIO), Madrid, Spain.
María José Juan-Fita Medical Oncology Department, Foundation of the Valencian Oncologic Institute, Valencia, Spain.
Isabel Tena Medical Oncology Department, Hospital Provincial de Castellón, Castellón, Spain.
Luis Robles Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
Carmen Guillén-Ponce Medical Oncology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Pedro Pérez-Segura Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
Mari Sol Luque-Molina Gynecological Department, Hospital Gregorio Marañón, Madrid, Spain.
Susana Hernando-Polo Medical Department, Hospital Fundación Alcorcón, Alcorcón, Spain.
Mónica Salinas Hereditary Cancer Program, Catalan Institue of Oncology-IDIBELL, Barcelona, Spain.
Joan Brunet Hereditary Cancer Program, Catalan Institute of Oncology-IDIBGI, Girona, Spain. .,Medical Sciences Department, School of Medicine, University of Girona, Girona, Spain.
María Dolores Salas-Trejo Foundation General Directorate Public Health and Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, FISABIO - Public Health, Valencia, Spain.
Agustí Barnadas Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Marina Pollán National Center for Epidemiology, Carlos III Institute of Health, Monforte de Lemos 5, 28029, Madrid, Spain. .,Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain. .,Consortium Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain.

Collapse

Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, Purrington K, Couch FJ, Brown J, Leyland J, Warren RML, Luben RN, Khaw KT, Smith P, Wareham NJ, Jud SM, Heusinger K, Beckmann MW, Douglas JA, Shah KP, Chan HP, Helvie MA, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman C, Giles GG, Baglietto L, Krishnan K, Southey MC, Apicella C, Andrulis IL, Knight JA, Ursin G, Alnaes GIG, Kristensen VN, Borresen-Dale AL, Gram IT, Bolla MK, Wang Q, Michailidou K, Dennis J, Simard J, Pharoah P, Dunning AM, Easton DF, Fasching PA, Pankratz VS, Hopper JL, Vachon CM. Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Res 2015;75:2457-67. [PMID: 25862352 PMCID: PMC4470785 DOI: 10.1158/0008-5472.can-14-2012] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2014] [Accepted: 03/10/2015] [Indexed: 12/30/2022]

Affiliation(s)

Jennifer Stone Centre for Genetic Origins of Health and Disease, University of Western Australia, Crawley, Western Australia, Australia
Deborah J Thompson Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Isabel Dos Santos Silva Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
Christopher Scott Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
Rulla M Tamimi Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Sara Lindstrom Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts
Peter Kraft Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Aditi Hazra Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Jingmei Li Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Human Genetics, Genome Institute of Singapore, Singapore, Singapore
Louise Eriksson Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Kamila Czene Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Per Hall Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Matt Jensen Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
Julie Cunningham Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota
Janet E Olson Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota
Kristen Purrington Department of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan
Fergus J Couch Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota. Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota
Judith Brown Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Jean Leyland Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Ruth M L Warren Department of Radiology, University of Cambridge, Addenbrooke's NHS Foundation Trust, Cambridge, United Kingdom
Robert N Luben Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Kay-Tee Khaw MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival (CNC), University of Cambridge, Cambridge, United Kingdom
Paula Smith Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
Nicholas J Wareham MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
Sebastian M Jud University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany
Katharina Heusinger University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany
Matthias W Beckmann University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany
Julie A Douglas Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan
Kaanan P Shah Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan
Heang-Ping Chan Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan
Mark A Helvie Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan
Loic Le Marchand University of Hawaii Cancer Center, Honolulu, Hawaii
Laurence N Kolonel University of Hawaii Cancer Center, Honolulu, Hawaii
Christy Woolcott Department of Obstetrics and Genecology, IWK Health Centre, Halifax, Canada
Gertraud Maskarinec University of Hawaii Cancer Center, Honolulu, Hawaii
Christopher Haiman Keck School of Medicine, University of Southern California, Los Angeles, California
Graham G Giles Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Laura Baglietto Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. Centre for Research in Epidemiology and Population Health, Gustave Roussy Institute, Villejuif Cedex, France. Paris-South University, Villejuif, France
Kavitha Krishnan Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Melissa C Southey Department of Pathology, University of Melbourne, Melbourne, Australia
Carmel Apicella Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Irene L Andrulis Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
Julia A Knight Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Giske Ursin Institute of Basic Medical Sciences, University of Oslo, Norway. Department of Preventive Medicine, University of Southern California, California
Grethe I Grenaker Alnaes Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Vessela N Kristensen Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Anne-Lise Borresen-Dale Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Inger Torhild Gram Faculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway
Manjeet K Bolla Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Qin Wang Faculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway
Kyriaki Michailidou Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Joe Dennis Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Jacques Simard Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada
Paul Pharoah Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
Alison M Dunning Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
Douglas F Easton Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom
Peter A Fasching University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany. Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
V Shane Pankratz Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
John L Hopper Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Celine M Vachon Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.

Collapse

Mammographic density and breast cancer risk by family history in women of white and Asian ancestry. Cancer Causes Control 2015;26:621-6. [PMID: 25761408 DOI: 10.1007/s10552-015-0551-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Accepted: 03/04/2015] [Indexed: 10/23/2022]

Brand JS, Humphreys K, Thompson DJ, Li J, Eriksson M, Hall P, Czene K. Volumetric Mammographic Density: Heritability and Association With Breast Cancer Susceptibility Loci. J Natl Cancer Inst 2014;106:dju334. [DOI: 10.1093/jnci/dju334] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open

Gierach GL, Li H, Loud JT, Greene MH, Chow CK, Lan L, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Olopade OI, Gail MH, Giger ML. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. Breast Cancer Res 2014. [PMID: 25159706 DOI: 10.1186/preaccept-1744229618121391] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open

Abstract

INTRODUCTION

Mammographic density is similar among women at risk of either sporadic or BRCA1/2-related breast cancer. It has been suggested that digitized mammographic images contain computer-extractable information within the parenchymal pattern, which may contribute to distinguishing between BRCA1/2 mutation carriers and non-carriers.

METHODS

We compared mammographic texture pattern features in digitized mammograms from women with deleterious BRCA1/2 mutations (n = 137) versus non-carriers (n = 100). Subjects were stratified into training (107 carriers, 70 non-carriers) and testing (30 carriers, 30 non-carriers) datasets. Masked to mutation status, texture features were extracted from a retro-areolar region-of-interest in each subject's digitized mammogram. Stepwise linear regression analysis of the training dataset identified variables to be included in a radiographic texture analysis (RTA) classifier model aimed at distinguishing BRCA1/2 carriers from non-carriers. The selected features were combined using a Bayesian Artificial Neural Network (BANN) algorithm, which produced a probability score rating the likelihood of each subject's belonging to the mutation-positive group. These probability scores were evaluated in the independent testing dataset to determine whether their distribution differed between BRCA1/2 mutation carriers and non-carriers. A receiver operating characteristic analysis was performed to estimate the model's discriminatory capacity.

RESULTS

In the testing dataset, a one standard deviation (SD) increase in the probability score from the BANN-trained classifier was associated with a two-fold increase in the odds of predicting BRCA1/2 mutation status: unadjusted odds ratio (OR) = 2.00, 95% confidence interval (CI): 1.59, 2.51, P = 0.02; age-adjusted OR = 1.93, 95% CI: 1.53, 2.42, P = 0.03. Additional adjustment for percent mammographic density did little to change the OR. The area under the curve for the BANN-trained classifier to distinguish between BRCA1/2 mutation carriers and non-carriers was 0.68 for features alone and 0.72 for the features plus percent mammographic density.

CONCLUSIONS

Our findings suggest that, unlike percent mammographic density, computer-extracted mammographic texture pattern features are associated with carrying BRCA1/2 mutations. Although still at an early stage, our novel RTA classifier has potential for improving mammographic image interpretation by permitting real-time risk stratification among women undergoing screening mammography.

Collapse

Gierach GL, Li H, Loud JT, Greene MH, Chow CK, Lan L, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Olopade OI, Gail MH, Giger ML. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. Breast Cancer Res 2014;16:424. [PMID: 25159706 PMCID: PMC4268674 DOI: 10.1186/s13058-014-0424-8] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2014] [Accepted: 07/31/2014] [Indexed: 12/24/2022] Open

Abstract

Introduction

Methods

We compared mammographic texture pattern features in digitized mammograms from women with deleterious BRCA1/2 mutations (n = 137) versus non-carriers (n = 100). Subjects were stratified into training (107 carriers, 70 non-carriers) and testing (30 carriers, 30 non-carriers) datasets. Masked to mutation status, texture features were extracted from a retro-areolar region-of-interest in each subject’s digitized mammogram. Stepwise linear regression analysis of the training dataset identified variables to be included in a radiographic texture analysis (RTA) classifier model aimed at distinguishing BRCA1/2 carriers from non-carriers. The selected features were combined using a Bayesian Artificial Neural Network (BANN) algorithm, which produced a probability score rating the likelihood of each subject’s belonging to the mutation-positive group. These probability scores were evaluated in the independent testing dataset to determine whether their distribution differed between BRCA1/2 mutation carriers and non-carriers. A receiver operating characteristic analysis was performed to estimate the model’s discriminatory capacity.

Results

Conclusions

Electronic supplementary material

The online version of this article (doi:10.1186/s13058-014-0424-8) contains supplementary material, which is available to authorized users.

Collapse

Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, Thompson EW. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 2014;144:479-502. [PMID: 24615497 DOI: 10.1007/s10549-014-2901-2] [Citation(s) in RCA: 120] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2013] [Accepted: 02/24/2014] [Indexed: 01/07/2023]

Varghese JS, Smith PL, Folkerd E, Brown J, Leyland J, Audley T, Warren RML, Dowsett M, Easton DF, Thompson DJ. The heritability of mammographic breast density and circulating sex-hormone levels: two independent breast cancer risk factors. Cancer Epidemiol Biomarkers Prev 2012;21:2167-75. [PMID: 23074290 DOI: 10.1158/1055-9965.epi-12-0789] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Barnes DR, Antoniou AC. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J Intern Med 2012;271:331-43. [PMID: 22443199 DOI: 10.1111/j.1365-2796.2011.02502.x] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]

Yaghjyan L, Colditz GA, Rosner B, Tamimi RM. Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer. Cancer Causes Control 2012;23:785-90. [PMID: 22438073 DOI: 10.1007/s10552-012-9936-7] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2011] [Accepted: 03/02/2012] [Indexed: 02/07/2023]

Abstract

PURPOSE

Few studies have investigated the association between breast density and breast cancer by a family history of breast cancer, menopausal status, and postmenopausal hormone use (PMH). We investigated if associations of breast density and breast cancer differ according to the status of these risk factors.

METHODS

This study included 1,481 incident breast cancer cases diagnosed within the Nurses' Health Study I and II cohorts and 2,779 matched controls. Breast density was measured from digitized film images with computerized techniques. Information on breast cancer risk factors was obtained prospectively from the biennial questionnaires before the date of the cancer diagnosis for cancer cases and their matched controls. The data were analyzed with logistic regression.

RESULTS

Breast cancer risk increased with increasing percent breast density in all strata (p for trend in all subsets <0.0001). The density-related risk of breast cancer was similar in women with and without a family history (OR = 4.00 [95 % CI 2.01-7.94] vs. 3.71 [95 % CI 2.79-4.94] for density ≥50 % vs. <10 %, p for interaction = 0.53). The magnitude of the association between density and breast cancer risk, however, appeared to be stronger in premenopausal women than in postmenopausal women without PMH history (OR = 5.49 [95 % CI 2.44-12.39] vs. 3.02 [95 % CI 1.62-5.63] for density ≥50 % vs. <10 %, p-heterogeneity = 0.17) and appeared to be stronger in postmenopausal women currently using hormones compared with postmenopausal women who never used PMH (OR = 4.50 [95 % CI 2.99-6.78] vs. 3.02, p-heterogeneity = 0.20) or with past hormone use (OR = 4.50 vs. 3.71 [95 % CI 1.90-7.23], p-heterogeneity = 0.23).

CONCLUSIONS

Findings on associations by menopausal status/hormone use are suggestive and should be examined in additional larger studies.

Collapse

Varghese JS, Thompson DJ, Michailidou K, Lindström S, Turnbull C, Brown J, Leyland J, Warren RML, Luben RN, Loos RJ, Wareham NJ, Rommens J, Paterson AD, Martin LJ, Vachon CM, Scott CG, Atkinson EJ, Couch FJ, Apicella C, Southey MC, Stone J, Li J, Eriksson L, Czene K, Boyd NF, Hall P, Hopper JL, Tamimi RM, Rahman N, Easton DF. Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res 2012;72:1478-84. [PMID: 22266113 PMCID: PMC3378688 DOI: 10.1158/0008-5472.can-11-3295] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]

Affiliation(s)

Jajini S Varghese Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Deborah J Thompson Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Kyriaki Michailidou Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Sara Lindström Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
Clare Turnbull Section of Cancer Genetics, The Institute of Cancer Research, Sutton, Surrey, UK
Judith Brown Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jean Leyland Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Ruth ML Warren Department of Radiology, University of Cambridge, Addenbrooke’s NHS Foundation Trust Cambridge, UK
Robert N Luben Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Ruth J Loos MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK
Nicholas J Wareham MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK
Johanna Rommens Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
Andrew D Paterson Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Lisa J Martin Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada
Celine M Vachon Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Christopher G Scott Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Elizabeth J Atkinson Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Fergus J Couch Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Carmel Apicella Centre for M.E.G.A. Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
Melissa C Southey Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia
Jennifer Stone Centre for M.E.G.A. Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
Jingmei Li Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Human Genetics, Genome Institute of Singapore, Singapore
Louise Eriksson Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Kamila Czene Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Norman F Boyd Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada
Per Hall Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
John L Hopper Centre for M.E.G.A. Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
Rulla M Tamimi Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA Channing Laboratory, Brigham and Women’s Hospital, Boston, MA, USA
Nazneen Rahman Section of Cancer Genetics, The Institute of Cancer Research, Sutton, Surrey, UK
Douglas F Easton Centre for Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK

Collapse

Martin LJ, Melnichouk O, Guo H, Chiarelli AM, Hislop TG, Yaffe MJ, Minkin S, Hopper JL, Boyd NF. Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2010;19:456-63. [PMID: 20142244 DOI: 10.1158/1055-9965.epi-09-0881] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Genetic influences on mammographic density in Korean twin and family: the Healthy Twin study. Breast Cancer Res Treat 2010;124:467-74. [DOI: 10.1007/s10549-010-0852-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2009] [Accepted: 03/16/2010] [Indexed: 11/26/2022]

Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 2010;123:245-55. [PMID: 20130984 DOI: 10.1007/s10549-010-0749-7] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2010] [Accepted: 01/13/2010] [Indexed: 11/26/2022]